BridgeMD
Does the Length of Surfactant Treatment Affect How Well Very Premature Babies Stabilize? – Comparing 1-Minute and 5-Minute Methods
EU CTIS ID: 2025-522754-39-00
What this study is testing
Objective of this clinical trial is to assess differences in SpO2, HR and crSO2, in accordance to the group randomisation of the duration of surfactant administration (“1min” vs. “5 min”) during the LISA procedure in preterm neonates < 28 weeks of gestational age during the first 72 hours after birth.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Preterm neonate <28+0 weeks (gestational age up to 27 weeks and 6 days)
- Indication of surfactant administration via the LISA method
- Postnatal age < 72 hours
You likely can't join if
- Invasive ventilation, indication of INSURE procedure
- Severe pulmonary or cardial malformation affecting oxygenation or congenital cerebral malformation
- Preexisiting diagnose of any IVH > grade 2 or PVH.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.